Literature DB >> 7567729

Radiotherapy and chemotherapy for inoperable non-small cell lung cancer.

C Bleasdale1, B Jones.   

Abstract

Non-small cell lung cancer is a major cause of mortality and significant morbidity in the UK. The majority of patients are inoperable and the optimum management of these patients requires a multidisciplinary approach involving the cooperation of respiratory physicians, thoracic surgeons and clinical oncologists (radiotherapists). Treatment techniques are constantly being refined and new approaches developed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567729      PMCID: PMC2397979          DOI: 10.1136/pgmj.71.837.393

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  18 in total

1.  Management of superior vena cava syndrome.

Authors:  C A Perez; C A Presant; A L Van Amburg
Journal:  Semin Oncol       Date:  1978-06       Impact factor: 4.929

Review 2.  Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy?

Authors:  D G Payne
Journal:  J Clin Oncol       Date:  1988-03       Impact factor: 44.544

Review 3.  Radiation therapy for medically inoperable stage I and II non-small cell lung cancer.

Authors:  J G Armstrong; B D Minsky
Journal:  Cancer Treat Rev       Date:  1989-12       Impact factor: 12.111

4.  Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron.

Authors:  P A Burt; B R O'Driscoll; H M Notley; P V Barber; R Stout
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

5.  Primary tumor control after radiotherapy for carcinoma of the bronchus.

Authors:  M I Saunders; M H Bennett; S Dische; P J Anderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-04       Impact factor: 7.038

6.  Endobronchial irradiation for malignant airway obstruction.

Authors:  M P Mehta; S Shahabi; N N Jarjour; T J Kinsella
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-10       Impact factor: 7.038

7.  Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

Authors:  P Price; P J Hoskin; D Easton; D Austin; S G Palmer; J R Yarnold
Journal:  Radiother Oncol       Date:  1986-08       Impact factor: 6.280

8.  A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis.

Authors:  J C Flickinger; D Kondziolka; L D Lunsford; R J Coffey; M L Goodman; E G Shaw; W R Hudgins; R Weiner; G R Harsh; P K Sneed
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-03-01       Impact factor: 7.038

9.  Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer.

Authors:  M Carroll; S A Morgan; J R Yarnold; J M Hill; N M Wright
Journal:  Eur J Cancer Clin Oncol       Date:  1986-11

10.  Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.

Authors: 
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.